Extended rewards program to reduce alcohol use for people living with HIV
Novel Extensions of Alcohol Contingency Management in People Living with HIV
['FUNDING_P01'] · UNIVERSITY OF FLORIDA · NIH-11163403
This project seeks to help people living with HIV drink less by using rewards, a smartphone app, wearable alcohol sensors, and game-like social features.
Quick facts
| Phase | ['FUNDING_P01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF FLORIDA (nih funded) |
| Locations | 1 site (GAINESVILLE, UNITED STATES) |
| Trial ID | NIH-11163403 on ClinicalTrials.gov |
What this research studies
You would be offered tangible rewards for reducing alcohol use delivered through a mobile app connected to an alcohol biosensor you wear. The program combines contingency management with gamification and social features to keep people engaged and aims to sustain benefits beyond a short reward period. About 120 participants will be enrolled and the work will take place in partnership with community health centers to see how the approach works in real clinic settings. The team is testing methods that could be spread to more clinics if they prove practical and effective.
Who could benefit from this research
Good fit: People living with HIV who drink alcohol regularly and are willing to use a smartphone app, wear an alcohol biosensor, and accept contingent rewards are the ideal candidates.
Not a fit: People who do not drink, who refuse to use mobile devices or wearable sensors, or who need intensive inpatient addiction treatment are unlikely to benefit from this outpatient rewards program.
Why it matters
Potential benefit: If successful, this approach could help people with HIV cut down on drinking and reduce alcohol-related harms that worsen HIV outcomes.
How similar studies have performed: Contingency management has reduced alcohol use in general-population studies and preliminary data from a related project including people with HIV are promising, but there are no published CM trials focused specifically on people living with HIV yet.
Where this research is happening
GAINESVILLE, UNITED STATES
- UNIVERSITY OF FLORIDA — GAINESVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LEEMAN, ROBERT F. — UNIVERSITY OF FLORIDA
- Study coordinator: LEEMAN, ROBERT F.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus